Source:http://linkedlifedata.com/resource/pubmed/id/17698993
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
2007-12-24
|
pubmed:abstractText |
Addiction is characterized by compulsive drug use despite adverse consequences. The precise psychobiological changes that underlie the progression from casual use to loss of control over drug-seeking and drug-taking behavior are not well understood. Here we report that short-term cocaine exposure in monkeys is sufficient to produce both selective deficits in cognitive functions dependent on the orbitofrontal cortex (OFC) concurrent with enhancements in motivational processes involving limbic-striatal regions. Additional findings from behavioral studies and analyses of the synaptic proteome provide new behavioral and biochemical evidence that cocaine-induced neuroadaptations in cortical and subcortical brain regions result in dysfunctional decision-making abilities and loss of impulse control that in combination with enhancements of incentive motivation may contribute to the development of compulsive behavior in addiction.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0077-8923
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
1121
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
610-38
|
pubmed:meshHeading |
pubmed-meshheading:17698993-Adaptation, Physiological,
pubmed-meshheading:17698993-Animals,
pubmed-meshheading:17698993-Behavior, Addictive,
pubmed-meshheading:17698993-Cocaine,
pubmed-meshheading:17698993-Cognition Disorders,
pubmed-meshheading:17698993-Frontal Lobe,
pubmed-meshheading:17698993-Primates,
pubmed-meshheading:17698993-Proteomics
|
pubmed:year |
2007
|
pubmed:articleTitle |
Orbitofrontal cortex and cognitive-motivational impairments in psychostimulant addiction: evidence from experiments in the non-human primate.
|
pubmed:affiliation |
Department of Psychiatry, Division of Molecular Psychiatry, Yale University, New Haven, CT 06508, USA. peter.olausson@yale.edu
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|